LifeSteps Financial’s Gilead Sciences GILD Stock Holding History

LifeSteps Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.9K	Buy	+181	New	+$23.8K	0.01%	291

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

LifeSteps Financial's GILD Position: Q2 2026 in Review

LifeSteps Financial opened a new position in Gilead Sciences (GILD) in Q2 2026: 181 shares worth $22.9K. The stake represents 0.01% of the portfolio and ranks #291 among its holdings.

965 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

LifeSteps Financial held 181 shares of Gilead Sciences worth $22.9K as of Q2 2026.
Gilead Sciences was a new LifeSteps Financial position in Q2 2026.
Gilead Sciences made up 0.01% of LifeSteps Financial's portfolio in Q2 2026, its #291 holding.
965 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.